Ocuphire Pharma Investor Update

13 Ocuphire PHARMA MIRA-3 Topline Phase 3 Results Randomized, Parallel Arm, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis in Healthy Subjects

View entire presentation